Fundz

Xencor Inc reported raising $25 Million in an initial SEC Form D filing, from an offering of $25 Million

PUBLIC · XNCRNov 19, 2021

Amount Raised

$25 Million

$25 Million sold, per SEC Form D (first sale Nov 19, 2021)

Round Type

Venture

PasadenaBiotechnologyHealth CareTherapeuticsBiopharma

Quick answer

Xencor raised $25 Million in a funding round, dated November 19, 2021. Xencor is based in Pasadena, California, United States.

How much did Xencor raise?
Xencor raised $25 Million in a funding round on November 19, 2021.
What does Xencor do?
Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of patients with cancer and other serious diseases.
Where is Xencor based and how big is it?
Xencor is based in Pasadena, California, United States.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biopharma around the same time

Companies in the same sectors as Xencor that raised within 45 days of this round, from Fundz verified event records.

  • Arbutus raised $15M on December 30, 2021.
  • AnHeart Therapeutics raised $61M (Series B) on December 14, 2021.
  • AEON Biopharma raised $30M on December 8, 2021.
  • Acrivon Therapeutics raised $100M on November 23, 2021.
  • Acrivon Therapeutics raised $100M (Series B) on November 11, 2021.
  • Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raised an undisclosed amount (Debt Financing) on October 18, 2021.

Who to call at Xencor, and when

A new round usually means Xencor is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Xencor raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Xencor, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Xencor. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Xencor

Location

Pasadena, California, United States

About

Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of patients with cancer and other serious diseases. More than 20 candidates engineered with Xencor's XmAb® technology are in clinical development, and three XmAb medicines are marketed by partners. Xencor's XmAb engineering technology enables small changes to a protein's structure that result in new mechanisms of therapeutic action. For more information, please visit www.xencor.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Xencor raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Xencor's next move

See what Strategic adds

Xencor raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.